Analgesics - United Arab Emirates

In the United Arab Emirates, the revenue generated in the Analgesics market reached US$126.40m in 2024.
It is projected that the market will experience an annual growth rate of 7.40% (CAGR 2024-2029).
When compared globally, the United States leads the market in terms of revenue, with a total of US$7.24bn in 2024.
Taking into account the population figures, per person revenues amount to US$13.18 in 2024.
The United Arab Emirates' market for analgesics in the OTC Pharmaceuticals industry is experiencing a surge in demand due to the growing population and increasing awareness of self-medication.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in United Arab Emirates has experienced significant growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market have shifted towards a preference for over-the-counter (OTC) pain relief products. This can be attributed to the convenience and accessibility of OTC medications, which do not require a prescription and can be easily purchased at pharmacies or supermarkets. Additionally, customers are increasingly seeking fast-acting and long-lasting pain relief solutions, leading to a rise in demand for analgesics with extended-release formulations.Trends in the market indicate a growing demand for natural and herbal analgesics. This trend is driven by a rising awareness among consumers about the potential side effects of synthetic pain medications and a preference for more natural and holistic approaches to pain management. As a result, companies in the Analgesics market are introducing a wide range of natural and herbal products to cater to this growing demand.Local special circumstances in the United Arab Emirates also play a role in shaping the development of the Analgesics market. The country has a high prevalence of chronic conditions such as arthritis and back pain, which drive the demand for analgesics. Additionally, the United Arab Emirates has a large expatriate population, which contributes to the market growth as expatriates often rely on analgesics to manage pain and discomfort.Underlying macroeconomic factors further contribute to the growth of the Analgesics market in the United Arab Emirates. The country's strong economic growth and increasing disposable incomes have led to higher healthcare spending, including the purchase of analgesics. Furthermore, the government's focus on improving healthcare infrastructure and increasing access to healthcare services has also contributed to the growth of the market.In conclusion, the Analgesics market in the United Arab Emirates is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards OTC medications, the demand for natural and herbal analgesics, the prevalence of chronic conditions, and the country's economic growth all contribute to the development of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.